Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)

IntroductionThe development of several effective biological drugs for moderate-to-severe plaque psoriasis has dramatically changed the lives of patients. Despite the wide use of interleukin (IL) inhibitors, limited data are available to date regarding long-term treatment persistence.MethodThis multi...

Description complète

Détails bibliographiques

Auteurs principaux:	Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G. Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Francesca M. Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2024-01-01
Collection:	Frontiers in Immunology
Sujets:	IL-inhibitors immunomodulatory therapies inflammatory skin diseases psoriasis psoriasis treatment
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1341708/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!